Lv4
410 积分 2023-10-09 加入
Diagnostic Accuracy of Noninvasive Tests for Metabolic Dysfunction-associated Steatotic Liver Disease Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study
18天前
已关闭
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia
26天前
已完结
Participation in the National Campaign on Viral Hepatitis C and Non-Communicable Diseases among Administrative Workers of Ain Shams University, Egypt
26天前
已完结
Egypt's hepatitis success story
26天前
已完结
Population-Based Return on Investment of Deploying Transient Elastography
26天前
已关闭
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes
26天前
已完结
1043-P: Screening for Presence of High-Risk Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) In the U.S. Primary Care Is Cost Effective
26天前
已完结
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
29天前
已完结
Optimal Population Screening Strategies for Liver Fibrosis Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease
1个月前
已完结
Cost‐effectiveness study of FIB‐4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at‐risk population
1个月前
已完结
皖公网安备34019202002308
